Clinical Benefit of Insulin Glargine 300 U/mL Among Type 2 Diabetes Mellitus Patients Previously Uncontrolled On Basal or Premixed Insulin in Serbia: A Prospective, Observational, Single-Arm, Multi-Center, Real World Study
posted on 2021-05-18, 16:17authored byMilena VELOJIC-GOLUBOVIC, Vojislav CIRIC, Marija DIMITRIJEVIC, Tijana KOVIC, Milica MITIC, Biljana OLUJIC, Natasa PEVAC, Sasa RADENKOVIC, Danijela RADOJKOVIC, Selena VUKADINOVIC, Djordje S. POPOVIC
Article full
text
The above summary slide represents
the opinions of the authors. For a full list of declarations, including funding
and author disclosure statements, please see the full text online (see “read
the peer-reviewed publication” opposite).